(g) iNOS expression was determined in the above samples using specific anti-iNOS antibody using celigo cytometer.
TWEAK and Fn14 expression was determined in anogenital warts and normal skin.
The dual-luciferase assay reporter assay detected LHX6 as the direct target gene of miR-214, and down-regulation of LHX6 expression was determined in HCC827/ER cells.
After seven days, cytokine expression was determined in proliferating (CFSElow) and non-proliferating (CFSEhigh) CD3+CD4+ T cells before and after stimulation with CD3 antibodies.
The analysis of MT1A, MT1E, MT1X, MT2, MT3 gene mRNA expression was determined in n = 51, n = 53, n = 49, n = 55, n = 51 glioma patients respectively.
To investigate the progression of HF, LV gene expression was determined in young mice with mildly diminished cardiac function and in older mice with severely impaired cardiac function.
HLA expression was determined in relation to EBV status.
Cleaved PARP protein expression was determined in the cell lysates by Western analysis.
Differential gene expression was determined in Partek Genomics Suite with the criteria described in Materials and Methods.
For functional characterization of CYP2C93, mRNA expression was determined in various tissues and protein expression was analyzed in liver.
AREG and EREG mRNA expression was determined in 106 and 105 patients for whom tumour material was available respectively, while PTEN expression was evaluated in 106 patients.
